Safety and preliminary efficacy of allogeneic bone marrow-derived mesenchymal stromal cells (BMSC) for painful lumbar facet arthropathy: study protocol for a randomised, double-blinded, placebo-controlled, crossover phase II clinical trial.
- DOI
- 10.1136/bmjopen-2025-113509
- Published
- 2026 Jul 20
- Container
- BMJ open
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/bmjopen-2025-113509,
title = {Safety and preliminary efficacy of allogeneic bone marrow-derived mesenchymal stromal cells (BMSC) for painful lumbar facet arthropathy: study protocol for a randomised, double-blinded, placebo-controlled, crossover phase II clinical trial.},
author = {Yan D and Durand NC and Wang Z and Osborne MD and Stone JA and Gupta S and Miller DA and Witter DM and Eldrige JS and Quiñones-Hinojosa A and Zubair AC and Qu W},
year = {2026},
journal = {BMJ open},
doi = {10.1136/bmjopen-2025-113509},
url = {https://doi.org/10.1136/bmjopen-2025-113509}
}RIS
TY - JOUR TI - Safety and preliminary efficacy of allogeneic bone marrow-derived mesenchymal stromal cells (BMSC) for painful lumbar facet arthropathy: study protocol for a randomised, double-blinded, placebo-controlled, crossover phase II clinical trial. AU - Yan D AU - Durand NC AU - Wang Z AU - Osborne MD AU - Stone JA AU - Gupta S AU - Miller DA AU - Witter DM AU - Eldrige JS AU - Quiñones-Hinojosa A AU - Zubair AC AU - Qu W PY - 2026 JO - BMJ open DO - 10.1136/bmjopen-2025-113509 UR - https://doi.org/10.1136/bmjopen-2025-113509 ER -
APA
D, Y., NC, D., Z, W., MD, O., JA, S., S, G., DA, M., DM, W., JS, E., A, Q., AC, Z., & W, Q. (2026). Safety and preliminary efficacy of allogeneic bone marrow-derived mesenchymal stromal cells (BMSC) for painful lumbar facet arthropathy: study protocol for a randomised, double-blinded, placebo-controlled, crossover phase II clinical trial.. BMJ open. https://doi.org/10.1136/bmjopen-2025-113509
Source records
- pubmed · retrieved 2026-09-25T22:25:13.776Z
- europe-pmc · retrieved 2026-09-25T22:25:13.781Z
- doaj · retrieved 2026-09-25T22:25:13.782Z